Close Menu

NEW YORK (GenomeWeb) – Strata Oncology said today that it has partnered with the University of California, San Francisco to launch a new initiative called StratifyProstate, which aims to expand access to precision medicine for men with metastatic prostate cancer by accelerating clinical trial enrollment.

Under the initiative, eligible metastatic prostate cancer patients anywhere in the United States can now receive no-cost NGS testing via enrollment in the Strata Trial, an observational study sponsored by Strata to study the impact of sequencing on clinical trial enrollment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.